Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye

Inclusion Criteria: * Signed ICF (Informed Consent Form) and data protection form * Patient-reported history of DED in both eyes * Have an Ocular Surface Disease Index (OSD) score ≥ 25 at Visit 1 * Have Meibomian Gland Dysfunction (MGD) at Visit 1. * Ability and willingness to follow instructions, including participation in all study assessments and visits Exclusion Criteria: * Women who are pregnant, nursing or planning a pregnancy * Ocular surface pathology, clinically significant slit-lamp findings, abnormal lid anatomy, active ocular allergies * Wear of contact lenses * Known allergy or sensitivity to the medical device or its components * Currently enrolled in an investigational drug or device study or have used an investigational drug or device within 60 days before Visit 1. * Clinical site employees or immediate family members of the same